T Cell Reagent Research for Monitoring T Cell in Food Allergy

用于监测食物过敏 T 细胞的 T 细胞试剂研究

基本信息

  • 批准号:
    10094186
  • 负责人:
  • 金额:
    $ 35.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-02-07 至 2023-01-31
  • 项目状态:
    已结题

项目摘要

Food allergy (FA) is now a major public health concern. Food allergy is both common—affecting ~8% of US children—and costly—resulting in ~$24.8 billion dollars per year in expenditures by the healthcare system and U.S. families. Approximately 40% of children with food allergy have experienced a severe, life-threatening allergic reaction, and 30% report allergies to multiple foods. Few studies have been conducted to track FA-specific T cells over time using epitopes and tetramer technology during the course of OIT. We hypothesize that distinctive patterns of T cell responses occur throughout OIT to shrimp or milk or cashew, and these can be revealed by immunophenotyping of cells responding to specific epitopes, including RNA-Seq assays, ATAC-Seq assays and TCR repertoire analyses. The results of the proposed studies will enable the production of useful tools for T cell reagents for shrimp, milk, and cashew allergens. Moreover, if the study aims are met, we will be able to further our knowledge of natural tolerance vs persistence vs treatment responsive vs treatment refractory shrimp, milk, or cashew allergy. Building upon our previous research in OIT, we propose a single clinical study to obtain fresh blood samples to optimize T cell reagent discovery and validation and, simultaneously, test the T cell reagent tools for their diagnostic, prognostic, and mechanistic use in food allergic patients before, during, and after OIT. Furthermore, we will identify, characterize, and validate new T cell epitopes for important food allergens not previously examined, such as milk, cashew, and shrimp. We will focus on epitope identification and validation, track the numbers and functions of epitope-specific T cells during stages of food allergy OIT, and then associate these parameters with careful phenotypic and endotypic characterizations in food allergic individuals. Our overall objectives are to conduct groundbreaking research in the areas of allergen epitope-specific T cell reagent identification and application to understanding mechanisms of food allergy. To advance these objectives, the PI(Nadeau) will work with Drs. Pulendran,Chang,Davis,Elias,Chinthrajah,Maecker, Andorf, and Desai.
食物过敏(FA)是一个主要的公共卫生问题。 食物过敏是常见的-影响约8%的美国儿童-和昂贵的-导致医疗保健系统和美国家庭每年约248亿美元的支出。 大约40%的食物过敏儿童经历过严重的、危及生命的过敏反应,30%的儿童报告对多种食物过敏。 在OIT过程中,很少有研究使用表位和四聚体技术随时间追踪FA特异性T细胞。 我们假设,在OIT中,对虾、牛奶或腰果的T细胞反应发生了独特的模式,这些可以通过对特定表位反应的细胞进行免疫表型分析来揭示,包括RNA-Seq测定、ATAC-Seq测定和TCR库分析。拟议研究的结果将使生产有用的工具,用于虾,牛奶和腰果过敏原的T细胞试剂。此外,如果达到研究目的,我们将能够进一步了解天然耐受性与持久性与治疗反应性与治疗难治性虾,牛奶或腰果过敏。基于我们以前在OIT中的研究,我们提出了一项单一的临床研究,以获得新鲜血液样本,以优化T细胞试剂的发现和验证,同时,测试T细胞试剂工具在OIT之前,期间和之后用于食物过敏患者的诊断,预后和机制。此外,我们将确定,表征和验证重要的食物过敏原,如牛奶,腰果和虾的新的T细胞表位。 我们将专注于表位识别和验证,跟踪表位特异性T细胞在食物过敏OIT阶段的数量和功能,然后将这些参数与食物过敏个体的表型和内型特征相关联。我们的总体目标是在过敏原表位特异性T细胞试剂鉴定和应用领域进行突破性研究,以了解食物过敏的机制。 为了推进这些目标,PI(Nadeau)将与Pulendran、Chang、Davis、Elias、Chinthrajah、Maecker、Andorf和Desai博士合作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kari C. Nadeau其他文献

Identification , Characterization , and initial epitope mapping of a pine nut allergen
松子过敏原的鉴定、表征和初始表位作图
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yuzhu Zhang;Wen;Yuting Fan;Jiang Yi;S. Lyu;Kari C. Nadeau;Tara H. McHugh
  • 通讯作者:
    Tara H. McHugh
Baseline epitope-specific IgE profiles are predictive of sustained unresponsiveness or high threshold 1-year post oral immunotherapy in the POISED trial
在“口服免疫治疗疗效和安全性评估(POISED)”试验中,基线表位特异性免疫球蛋白E(IgE)谱可预测口服免疫治疗1年后持续无反应或高阈值反应情况。
  • DOI:
    10.1016/j.jaci.2024.10.017
  • 发表时间:
    2025-03-01
  • 期刊:
  • 影响因子:
    11.200
  • 作者:
    Maria Suprun;Ashley Sang Eun Lee;Robert Getts;Simon Peck;Sayantani B. Sindher;Kari C. Nadeau;R. Sharon Chinthrajah;Stephen J. Galli;Hugh A. Sampson
  • 通讯作者:
    Hugh A. Sampson
Novel dosing strategy of omalizumab during multi-allergen oral-immunotherapy
  • DOI:
    10.1016/j.waojou.2020.100415
  • 发表时间:
    2020-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sayantani B. Sindher;Andrew Long;Natasha Purington;Divya Kumar;Stacey Skura;Margaret A. Woch;Tiffany Tan;Andres Alvarez;R. Sharon Chinthrajah;Maria Garcia-Lloret;Kari C. Nadeau
  • 通讯作者:
    Kari C. Nadeau
How does global warming contribute to disorders originating from an impaired epithelial barrier?
全球变暖如何导致源自上皮屏障受损的疾病?
  • DOI:
    10.1016/j.anai.2023.08.010
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
    4.700
  • 作者:
    Cevdet Ozdemir;Umut Can Kucuksezer;Ismail Ogulur;Yagiz Pat;Duygu Yazici;Ioana Agache;Marek Jutel;Kari C. Nadeau;Mübeccel Akdis;Cezmi A. Akdis
  • 通讯作者:
    Cezmi A. Akdis
Decreased Migratory Potential of Treg Cells in CRSwNP
  • DOI:
    10.1016/j.otohns.2010.06.707
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Amanda Munoz;Kari C. Nadeau;Peter H. Hwang
  • 通讯作者:
    Peter H. Hwang

Kari C. Nadeau的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kari C. Nadeau', 18)}}的其他基金

Clinical Core
临床核心
  • 批准号:
    10584556
  • 财政年份:
    2022
  • 资助金额:
    $ 35.21万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10419277
  • 财政年份:
    2022
  • 资助金额:
    $ 35.21万
  • 项目类别:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
空气污染扰乱心肺总体健康中的炎症小体调节 (AIRHEALTH)
  • 批准号:
    10460326
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
空气污染的管理核心扰乱心肺总体健康(AIRHEALTH)研究中的炎症小体调节
  • 批准号:
    10269331
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10491675
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    10687221
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Administrative Core for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
空气污染的管理核心扰乱心肺总体健康(AIRHEALTH)研究中的炎症小体调节
  • 批准号:
    10684157
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH)
空气污染扰乱心肺总体健康中的炎症小体调节 (AIRHEALTH)
  • 批准号:
    10684155
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
遗传、生活方式和环境因素之间的相互作用决定循环血管紧张素转换酶 2 蛋白表达:对 COVID-19 感染严重程度的影响
  • 批准号:
    10228516
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:
Project 1 for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) Study
空气污染扰乱心肺总体健康 (AIRHEALTH) 研究中的炎症小体调节项目 1
  • 批准号:
    10684167
  • 财政年份:
    2021
  • 资助金额:
    $ 35.21万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 35.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了